Polymarket may have dramatically widened the scope of its testing as the Commodity Futures Trading Commission (CFTC) finally published the self-certification filings that appeared to be holding up the ...
GeneDx leverages a vast rare disease database and advanced genomic testing, offering superior insights over traditional panel testing. The company achieved a significant turnaround, becoming cash flow ...
Q4 2025 Management View CEO Lishan Aklog reported that "our EsoGuard test volume in the fourth quarter was 3,664. That exceeds our target range that we've articulated regularly of approximately 2,500 ...
Fulgent’s arsenal has expanded to include a monkeypox test. Just as its record testing run for Covid-19 appears to be tapering off, Temple City-based Fulgent Genetics Inc. has added testing for ...
New Lab Volume Index, Highlighting More Trends and Expanded Functionality, Shows Testing Capacity Being Absorbed by Doubling of Demand for Women’s Health, Led by Prenatal Testing New Lab Volume Index, ...
Baron Funds, an investment management company, released its “Baron Discovery Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund ...
Authorized for use in the U.S. in January 2021, Ortho's VITROS® SARS-CoV-2 Antigen Test offers reliable detection of SARS-CoV-2 in patients suspected of COVID-19 by their healthcare provider within ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results